ZOM — Zomedica Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-19.8	-16.9	-18.4	-17	-34.5
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	3.33	1.86	6.84	7.01	13.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.03	-1.72	-1.35	-3.35	-0.161
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-15.6	-16.2	-14.3	-11.7	-16
Capital Expenditures	-0.687	-0.017	-0.526	-2.79	-15.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	1.02	-71.4	-153	17.1
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.687	1.01	-71.9	-156	1.58
Financing Cash Flow Items	2.29	-5.11	-14.3	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14.9	76.7	219	0.008	—
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1.43	61.5	133	-168	-14.4